Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-22-003472
Filing Date
2022-03-11
Accepted
2022-03-11 17:17:49
Documents
125
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K srne-20211231.htm   iXBRL 10-K 5798278
2 EX-4.19 srne-ex4_19.htm EX-4.19 63424
3 EX-21.1 srne-ex21_1.htm EX-21.1 25295
4 EX-23.1 srne-ex23_1.htm EX-23.1 5985
5 EX-23.2 srne-ex23_2.htm EX-23.2 3910
6 EX-31.1 srne-ex31_1.htm EX-31.1 15880
7 EX-32.1 srne-ex32_1.htm EX-32.1 10063
8 GRAPHIC img176110163_0.jpg GRAPHIC 26870
9 GRAPHIC img176110163_1.jpg GRAPHIC 177944
10 GRAPHIC img176110163_2.jpg GRAPHIC 46806
11 GRAPHIC img176110163_3.jpg GRAPHIC 296209
  Complete submission text file 0000950170-22-003472.txt   21808493

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT srne-20211231.xsd EX-101.SCH 129203
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT srne-20211231_lab.xml EX-101.LAB 946255
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT srne-20211231_def.xml EX-101.DEF 637488
15 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT srne-20211231_pre.xml EX-101.PRE 852989
16 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT srne-20211231_cal.xml EX-101.CAL 99564
119 EXTRACTED XBRL INSTANCE DOCUMENT srne-20211231_htm.xml XML 3854903
Mailing Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121
Business Address 4955 DIRECTORS PLACE SAN DIEGO CA 92121 858-203-4100
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

EIN.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36150 | Film No.: 22734088
SIC: 2836 Biological Products, (No Diagnostic Substances)